Quick Answer
Crinetics Pharmaceuticals, Inc. reported Net Income of -$465.32 million for fiscal year 2025.
Crinetics Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$465.32M | -55.9% |
| 2024 | -$298.41M | -39.1% |
| 2023 | -$214.53M | -30.9% |
| 2022 | -$163.92M | -52.3% |
| 2021 | -$107.64M | -45.8% |
| 2020 | -$73.81M | -46.4% |
| 2019 | -$50.42M | -86.0% |
| 2018 | -$27.11M | -196.1% |
| 2017 | -$9.16M | -52.1% |
| 2016 | -$6.02M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$130.09M | -69.3% | -12.5% |
| June 30, 2025 | -$115.64M | -56.2% | -19.5% |
| March 31, 2025 | -$96.77M | -44.6% | -26.0% |
| September 30, 2024 | -$76.83M | -33.7% | -3.7% |
| June 30, 2024 | -$74.06M | -45.3% | -10.6% |
| March 31, 2024 | -$66.93M | -45.5% | -16.5% |
| September 30, 2023 | -$57.46M | -37.0% | -12.7% |
| June 30, 2023 | -$50.98M | -20.3% | -10.8% |
- Crinetics Pharmaceuticals, Inc. showed a decrease of -55.9% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Crinetics Pharmaceuticals, Inc.’s net income has declined by 7630.8% (from -$6.02 million to -$465.32 million).
- The most recent figure is from Crinetics Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: